Rethinking Clinical Trials Grand Rounds: ACTIV-6 - A Direct-to-Participant Platform Trial of Repurposed Drugs for COVID-19
Date: Friday, April 30, 2021 1:00 pm - 2:00 pm
Categories:
Other Sponsor
ACTIV-6: A Direct-to-Participant Platform Trial of Repurposed Drugs for COVID-19 in Non-hospitalized Patients
This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features Susanna Naggie, MD, MHS, of Duke Clinical Research Institute and Elizabeth Shenkman, PhD, of the University of Florida.
Presenters
Susanna Naggie, MD, MHS
Associate Professor of Medicine
Duke Clinical Research Institute
Chair, Department of Health Outcomes and Biomedical Informatics
Co-Director, Clinical and Translational Science Institute (CTSI)
University of Florida